Sergio Carmona
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 0.5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- SARS-CoV-2 detection and testing
Papers in
- Virology 39
- HIV Research and Treatment 39
-
- HIV/AIDS Research and Interventions 49
- HIV/AIDS drug development and treatment 28
- SARS-CoV-2 detection and testing 12
- SARS-CoV-2 and COVID-19 Research 7
- Co-authors
- William MacLeodPatrick ArbuthnotWendy StevensMatthew P. FoxMhairi MaskewGayle ShermanJacob BorCarol Crowther
- Journals
- Journal of Clinical Microbiology (9 papers)PLoS ONE (8 papers)PLoS Medicine (7 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (5 papers)Journal of the International AIDS Society (4 papers)
- Partner nations
- South AfricaUnited StatesSwitzerland
In The Last Decade
Sergio Carmona
97 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 119
- Virology 748
- Infectious Diseases 1.6k
- Epidemiology 771
- Emergency Medicine 145
- General Health Professions 315
Countries citing papers authored by Sergio Carmona
This map shows the geographic impact of Sergio Carmona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Carmona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Carmona more than expected).
Fields of papers citing papers by Sergio Carmona
This network shows the impact of papers produced by Sergio Carmona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Carmona. The network helps show where Sergio Carmona may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergio Carmona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 12 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 38 | |
| 10 | 2022 | 21 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 176 | |
| 14 | 2020 | 36 | |
| 15 | 2020 | 19 | |
| 16 | 2020 | 18 | |
| 17 | 2020 | 16 | |
| 18 | 2019 | 20 | |
| 19 | 2019 | 35 | |
| 20 | 2018 | 33 |
About Sergio Carmona
Sergio Carmona is a scholar working on Virology, Infectious Diseases, Modeling and Simulation, Epidemiology and Applied Microbiology and Biotechnology, having authored 100 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (49 papers), HIV Research and Treatment (39 papers), HIV/AIDS drug development and treatment (28 papers), SARS-CoV-2 detection and testing (12 papers), HIV, Drug Use, Sexual Risk (10 papers), RNA Interference and Gene Delivery (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). The work is most often cited by research in Virology (748 citations), Infectious Diseases (1.6k citations), Epidemiology (771 citations), Emergency Medicine (145 citations) and General Health Professions (315 citations). Sergio Carmona has collaborated with scholars based in South Africa, United States and Switzerland. Frequent co-authors include William MacLeod, Patrick Arbuthnot, Wendy Stevens, Matthew P. Fox, Mhairi Maskew, Gayle Sherman, Jacob Bor, Carol Crowther, François Venter and Abdullah Ely. Their work appears in journals such as Journal of Clinical Microbiology, PLoS ONE, PLoS Medicine, JAIDS Journal of Acquired Immune Deficiency Syndromes and Journal of the International AIDS Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.